Nat. Rev. Gastroenterol. Hepatol. doi:10.1038/nrgastro.2015.172 Figure 2 The prevalence of metabolic risk factors and metabolic syndrome in liver transplant recipients Figure 2 | The prevalence of metabolic risk factors and metabolic syndrome in liver transplant recipients. Percentages in the left panel show the prevalence of respective risk factors that contribute to metabolic syndrome (obesity, diabetes, hypertension, hyperlipidaemia) in patients after transplantation. The right panel indicates how many percent of transplant recipients with HCV, NASH and alcoholic liver disease are diagnosed with metabolic syndrome. Aggregate percentages adapted from the literature;7,38,39,40 *Metabolic syndrome is diagnosed in 43-58% of liver transplant recipients and requires ≥3 of the criteria: fasting plasma glucose ≥5.5 mmol/l; waist circumference >102 cm (men), >88 cm (women) or BMI >30 as a surrogate; fasting triglyceride level ≥1.7 mmol/l or drug treatment; fasting HDL level <1.0 mmol/l (men), <1.3 mmol/l (women) or drug treatment; hypertension ≥140/90 mmHg or drug treatment. Watt, K. D. (2015) Keys to long-term care of the liver transplant recipient Nat. Rev. Gastroenterol. Hepatol. doi:10.1038/nrgastro.2015.172